期刊文献+

胰高糖素样肽-1(7-36)NH_2引起的胰岛β细胞内游离钙变化 被引量:4

Effect of glucagon-like peptide-1(7-36)NH_2 on cytoplasmic free Ca^(2+) in rat pancreatic β cells
在线阅读 下载PDF
导出
摘要 目的探讨胰高糖素样肽(GLP)-1(7-36)NH_2促胰岛素分泌的机制。方法以 Fluo-3为探针,用粘附式细胞仪研究 GLP- 1(7- 36)NH_2对培养的新生大鼠胰岛β细胞内游离 Ca^(2+)浓度的作用。结果在 2.8 mmol/L葡萄糖时,GLP- 1(7- 36)NH_2不能使胰岛 β细胞内游离 Ca^(2+)升高,而优降糖使β细胞内游离 Ca^(2+)升高明显。在 16.7 mmol/L葡萄糖时,GLP-1(7-36)NH_2使胰岛β细胞内Ca^(2+)升高明显,EGTA和硝苯吡啶能完全阻滞GLP-1(7-36)NH_2引起的Ca^(2+)升高。结论GLP-1(7-36)NH_2具有葡萄糖浓度依赖的促胰岛素释放作用,细胞外Ca^(2+)通过电压依赖性钙通道内流对其引起的β细胞内游离Ca^(2+)升高起重要作用。 Objective To explore the mechanisms by which GLP- l(7 - 36)NH_2 stimulates insulin release. Methods Using adherent cell analysis and sorting cytometer (ACAS) with Fluo - 3 as a probe, effect of glucagon - like peptidc - 1 (7 - 36)NH_2 on cytoplasmic Ca^(2+) concentalion was investigated in cultured neonatal rat pancreatic islst β - Cells. Results In the presence of 2. 8 mmol/ L glucose, GLP - 1 (7 - 36)NH_2 had no effect on cytoplasmic Ca^(2+) in β - Cells, but glybenclamide increased in cytoplasmic Ca^(2)+ in β- Cells. In the presence of 16.7 mmol/L glucose,GLP- l(7 - 36)NH_2 produced a marked increase in cytoplasmic Ca^(2+) in β - cells, which was completely inhibited by EGTA or nifedipine. Conclusion GLP - 1 (7 - 36) NH_2 can stimulate insulin release in a glucose concentration- dependent manner. Inflax of Ca^(2+) through voltage - dependent L - type Ca^(2+) channels plays an important role in increasing cytoplasmic Ca^(2+) in β - cells.
出处 《广东医学》 CAS CSCD 2000年第4期286-288,共3页 Guangdong Medical Journal
关键词 胰岛素 胰岛Β细胞 游离钙 GLP-1(7-36)NH2 GLP- l(7 - 36)NH_2 Pancreatic islet cell Culture Cytoplasmic Ca^(2+)
  • 相关文献

参考文献2

二级参考文献3

共引文献4

同被引文献24

  • 1巩秋红,娄晋宁,叶丽亚,李光伟.重组人胰高血糖素样肽1(7-36)促进INS-1细胞胰岛素释放与合成[J].中华内分泌代谢杂志,2004,20(6):559-560. 被引量:11
  • 2王川,严励,杨川,傅祖植,程桦.胰高糖素样肽1长期作用对RIN-m细胞胰岛素分泌功能的影响[J].中华内分泌代谢杂志,2006,22(1):75-76. 被引量:9
  • 3Leon DD,Crutchlow MF,Ham JY,et al. Role of glucagon-like peptide- 1 in the pathogenesis and treatment of diabetes mellitus[J]. Int J Biochem Cell Biol, 2006,38 : 845 - 859.
  • 4Nauck MA, Kleine N, Orskov C, et al. Normalization of fasting hyperglycemia by exogenous glucagons-like peptide 1 (7 - 36 amide) in type 2( non-insulin dependent) diabetic patients[J]. Diabetologia, 1993,36:741 - 744.
  • 5Grornada J,Broek B,Sehmits O,et al. Glucagon-like peptide- 1:regulation of insulin secretion and therapeutic potential[ J ]. Basic Clin Pharmacol Toxieol, 2004,95 : 252 - 262.
  • 6Dunning BE,Foley JE,Ahren B. Alpha cell function in health and disease:influence of glucagons-like peptide- 1 [J]. Diabetologia, 2005,48 : 1700 - 1713.
  • 7Farilla L, Bolotta A, Hisrshberg Bet al. Glucagon-like peptide- 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets[J]. Endocrinology,2003,144(12) :5149 - 5158.
  • 8DeFronzo RA, Ramer RE, Han J, et al. Effecta of exenatide (ex endin- 4) on glycemic control and weight over 30 weeks in met form-in-treated patients with type 2 diabetes [ J ]. Diabetes Care 2005,28(5) : 1092 - 1100.
  • 9Degn KB,Juhl CB, Sturis J, et al. One week's treatment with the long-acting glucagons-like peptide 1 derivative liraglutide(NN2211 ) markedly improves 24 h glycemia and alpha-and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes[J]. Diabetes,2004,2004,53(5) :1187 - 1194.
  • 10陶枫,朱蕴华,姚政,等.健脾清化汤对糖尿病模型大鼠GLP-1表达的影响[A].第十次全国中医糖尿病大会论文集[C].2007:663-668.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部